HFWA vs HQH
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
HFWA presents a compelling value opportunity, trading significantly below both its Graham Number ($34.59) and Intrinsic Value ($57.82). While the Piotroski F-Score of 4/9 indicates only stable financial health, the company is exhibiting explosive earnings growth (90.80% YoY) and a very attractive forward P/E of 9.35. Despite bearish insider sentiment and weak technical trends, the fundamental disconnect between the current price ($27.30) and the growth-adjusted value suggests a strong upside. The dividend remains sustainable with a payout ratio under 50%.
HQH presents a complex profile with a stable Piotroski F-Score of 5/9 and a significant valuation discount, trading well below its Graham Number ($26.72) and Intrinsic Value ($47.5). However, these value metrics are offset by severe fundamental deterioration, specifically a -48.70% YoY revenue decline and an unsustainable dividend payout ratio of 139.13%. While historical price performance is positive, the current technical trend is heavily bearish (10/100) and liquidity is tight with a current ratio of 0.77. The stock is a value trap candidate where low multiples are justified by declining growth and dividend risk.
Compare Another Pair
Related Comparisons
HFWA vs HQH: Head-to-Head Comparison
This page compares Heritage Financial Corporation (HFWA) and Abrdn Healthcare Investors (HQH) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.